What is Noblegen?
Founded in 2013, Noblegen operates at the forefront of the alternative protein industry. The company utilizes the microorganism Euglena gracilis to synthesize a versatile range of protein, carbohydrate, and oil ingredients. This unique biological approach allows Noblegen to address the growing global demand for sustainable, plant-based, and nutrient-dense food sources. By maintaining a vertically integrated production model, the company has positioned itself as a critical supplier for food manufacturers seeking to enhance the nutritional profile of their products while minimizing environmental impact. Their market position is defined by a commitment to innovation in cellular agriculture and the scalability of their fermentation processes.
How much funding has Noblegen raised?
Noblegen has raised a total of $67.5M across 2 funding rounds:
Series A
$42.5M
Series B
$25M
Series A (2016): $42.5M, investors not publicly disclosed
Series B (2019): $25M led by Richardson Ventures Inc and BDC's Cleantech Practice
Key Investors in Noblegen
Richardson Ventures Inc
A diversified investment firm that provides capital to high-growth companies, often focusing on long-term value creation in the Canadian market.
BDC's Cleantech Practice
A specialized division of the Business Development Bank of Canada that supports the growth of sustainable technology firms through strategic financing and advisory services.
Undisclosed Investor
An undisclosed investor participating in the funding round, providing essential capital to support the company's ongoing operational scaling.
What's next for Noblegen?
With the recent influx of capital, Noblegen is well-positioned to accelerate its commercialization efforts and expand its manufacturing capacity. The strategic focus will likely shift toward scaling production to meet enterprise-level demand and deepening its research and development pipeline. As the company matures, the emphasis will remain on optimizing the cost-efficiency of its Euglena-based ingredients to compete with traditional protein sources. Future growth will be contingent upon the successful integration of these ingredients into mainstream consumer packaged goods and the continued validation of their proprietary technology in global markets.
See full Noblegen company page
